Company / Capital Expenditures
GeneDx Holdings Corp. Capital Expenditures History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$19.0M
FY2025
5-year range
$5.3M / $19.0M
FY2021-FY2025
Trend
+246.3%
vs FY2024
Sector context
#101 of 145
Health Care
What the data says
Capital Expenditures changed +246% YoY in FY2025, a notable deviation from the 6-year average annual change of +40%.
Based on SEC 10-K filings.
$19M in FY2025 with a 5-year CAGR of -4.6%.
Improved from $5M to $19M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +38.5%
- 5-Year CAGR
- -4.6%
- 10-Year CAGR
- -
Sector benchmark
#101 of 145 in Health CareTop 70% of 145This company $19.0M Sector average $268.6M
▼
-92.9% below sector average
Key checks
Key Insights
- 5-year CAGR of -4.6%, indicating a declining trend.
- In FY2025, capital expenditures increased 246.3% year-over-year.
- Ranks #101 out of 145 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $19.0M | +246.3% |
| FY2024 | $5.5M | +4.6% |
| FY2023 | $5.3M | -26.6% |
| FY2022 | $7.2M | -23.9% |
| FY2021 | $9.4M | -61.0% |
| FY2020 | $24.1M | +102.1% |
| FY2019 | $11.9M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026